In the development of HCM from compensated to decompensated heart failure, we find that ROS levels increase, mitochondrial damage occurs, and the classical pro-oxidative pathway PI3K/AKT/FOXO3a is activated. This evidence concerns the gene FOXO3 and heart failure.